Scholarlink

<p>Several studies have reported a correlation between inflammatory bowel disease (IBD) and an elevated risk of various cancers. However, the relationship between IBD and the incidence of liver cancer remains inconclusive. To address this issue, we conducted a meta-analysis to examine the association between IBD and the risk of liver cancer. A systematic search of the Cochrane Library, Embase, Web of Science, and PubMed databases was performed to identify relevant studies published up to December 22, 2024. Our meta-analysis included nine cohort studies, comprising a total of 7,305,655 participants. The pooled results indicated that patients with IBD had an increased risk of developing liver cancer (RR = 1.80; 95% CI: 1.21–2.68; <i>p</i> &lt; 0.0001). An elevated risk was also observed among patients with Crohn’s disease (CD) (RR = 1.78; 95% CI: 1.21–2.62), although this result did not reach statistical significance (<i>p</i> = 0.0972). Additionally, female IBD patients (RR = 2.47; 95% CI: 1.35–4.54; <i>p</i> = 0.0442) exhibited a significantly higher risk of liver cancer compared to male patients. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association between inflammatory bowel disease and the risk of liver cancer: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月1日

查看全文
  • Yi Gu,
  • RongLong Kong,
  • An Ling,
  • ZhiChao Ma,
  • Cheng Lan,
  • GuiPing Chen

摘要

Several studies have reported a correlation between inflammatory bowel disease (IBD) and an elevated risk of various cancers. However, the relationship between IBD and the incidence of liver cancer remains inconclusive. To address this issue, we conducted a meta-analysis to examine the association between IBD and the risk of liver cancer. A systematic search of the Cochrane Library, Embase, Web of Science, and PubMed databases was performed to identify relevant studies published up to December 22, 2024. Our meta-analysis included nine cohort studies, comprising a total of 7,305,655 participants. The pooled results indicated that patients with IBD had an increased risk of developing liver cancer (RR = 1.80; 95% CI: 1.21–2.68; p < 0.0001). An elevated risk was also observed among patients with Crohn’s disease (CD) (RR = 1.78; 95% CI: 1.21–2.62), although this result did not reach statistical significance (p = 0.0972). Additionally, female IBD patients (RR = 2.47; 95% CI: 1.35–4.54; p = 0.0442) exhibited a significantly higher risk of liver cancer compared to male patients.